®®®® SIIA Público

Título del libro: Pharmacoresistance In Epilepsy: From Genes And Molecules To Promising Therapies, Second Edition
Título del capítulo: Modulating P-glycoprotein Regulation as a Therapeutic Strategy for Pharmacoresistant Epilepsy

Autores UNAM:
DANIELA PEREZ PEREZ; HIRAM LUNA MUNGUIA;
Autores externos:

Idioma:

Año de publicación:
2023
Palabras clave:

Cyclooxygenase-2; Drug-resistant Epilepsy; Efflux transporters; Glutamate; P-glycoprotein


Resumen:

Experimental data suggest a role of blood-brain barrier P-glycoprotein overexpression as a factor contributing to drug-resistant epilepsy. Therefore, efforts are made to develop and validate therapeutic approaches that aim to overcome transporter-mediated drug resistance. Considering the physiological function of efflux transporters, it will be advantageous to preserve the basal transport function. Thus, recent studies focused on the elucidation of key signaling factors driving P-glycoprotein upregulation in response to epileptic seizure activity. Based on these investigations, novel concepts have been developed: blocking the signaling pathway and controlling P-glycoprotein expression despite recurrent seizure activity. Further development of respective approaches is based on ongoing studies that explore the relevance of the signaling mechanisms in human capillaries and preclinical animal models. In general, the success of respective strategies will depend on the question of whether patients exist in which P-glycoprotein overexpression constitutes a predominant factor contributing to therapeutic failure. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2013, 2023.


Entidades citadas de la UNAM: